These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30936461)

  • 41. Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1.
    Zhu Y; Qu C; Hong X; Jia Y; Lin M; Luo Y; Lin F; Xie X; Xie X; Huang J; Wu Q; Qiu X; Piao D; Xing Y; Yu T; Lu Y; Huang Q; Yu C; Jin J; Zhang Z
    Cell Death Differ; 2019 Jan; 26(2):306-320. PubMed ID: 29748601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
    Lin HH; Feng WC; Lu LC; Shao YY; Hsu CH; Cheng AL
    Cancer Lett; 2016 Oct; 381(1):58-66. PubMed ID: 27431312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
    Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
    Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ILKAP Promotes the Metastasis of Hepatocellular Carcinoma Cells by Inhibiting β-Catenin Degradation and Enhancing the WNT Signaling Pathway.
    Zhang R; Yuan J; Liu S; Torraca V; Liao Z; Wu Y; Tan H; Yao X; Hou X; Lyu H; Xiao S; Guo D; Ali DW; Michalak M; Chen XZ; Zhou C; Tang J
    Adv Biol (Weinh); 2024 May; 8(5):e2300117. PubMed ID: 38379270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.
    Liu Y; Ye X; Zhang JB; Ouyang H; Shen Z; Wu Y; Wang W; Wu J; Tao S; Yang X; Qiao K; Zhang J; Liu J; Fu Q; Xie Y
    Oncogene; 2015 Oct; 34(44):5524-35. PubMed ID: 25684142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ATDC promotes the growth and invasion of hepatocellular carcinoma cells by modulating GSK-3β/Wnt/β-catenin signalling.
    Li W; Xue H; Li Y; Li P; Ma F; Liu M; Kong S
    Clin Exp Pharmacol Physiol; 2019 Sep; 46(9):845-853. PubMed ID: 31168819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
    Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
    Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling.
    Liu Y; Zhou R; Yuan X; Han N; Zhou S; Xu H; Guo M; Yu S; Zhang C; Yin T; Wu K
    Oncotarget; 2015 Apr; 6(11):8621-34. PubMed ID: 25940701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
    Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
    J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.
    Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY
    Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma.
    Xie P; Yu M; Zhang B; Yu Q; Zhao Y; Wu M; Jin L; Yan J; Zhou B; Liu S; Li X; Zhou C; Zhu X; Huang C; Xu Y; Xiao Y; Zhou J; Fan J; Hung MC; Ye Q; Guo L; Li H
    J Hepatol; 2024 Jul; 81(1):93-107. PubMed ID: 38403027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The β-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis.
    Huang WJ; Tian XP; Bi SX; Zhang SR; He TS; Song LY; Yun JP; Zhou ZG; Yu RM; Li M
    Oncogene; 2020 Jun; 39(23):4538-4550. PubMed ID: 32372060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma.
    Yang YF; Pan YH; Cao Y; Fu J; Yang X; Zhang MF; Tian QH
    Oncotarget; 2017 Jul; 8(29):47195-47205. PubMed ID: 28525379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling.
    Bai XL; Zhang Q; Ye LY; Liang F; Sun X; Chen Y; Hu QD; Fu QH; Su W; Chen Z; Zhuang ZP; Liang TB
    Oncogene; 2015 Jul; 34(31):4089-97. PubMed ID: 25328135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A-kinase interacting protein 1 (AKIP1) associates with advanced overall disease condition, tumor properties, and unfavorable prognosis in hepatocellular carcinoma patients.
    Fang T; Lu Q
    J Clin Lab Anal; 2020 Jun; 34(6):e23213. PubMed ID: 32133702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A SOX9-AS1/miR-5590-3p/SOX9 positive feedback loop drives tumor growth and metastasis in hepatocellular carcinoma through the Wnt/β-catenin pathway.
    Zhang W; Wu Y; Hou B; Wang Y; Deng D; Fu Z; Xu Z
    Mol Oncol; 2019 Oct; 13(10):2194-2210. PubMed ID: 31402556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Meningioma-associated protein 30 accelerates the proliferation and invasion of hepatocellular carcinoma by modulating Wnt/GSK-3β/β-catenin signaling.
    Zhang Y; Li H; Wang J; Geng X; Hai J
    J Bioenerg Biomembr; 2021 Feb; 53(1):73-83. PubMed ID: 33405049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists.
    Yuan J; Han B; Hu H; Qian Y; Liu Z; Wei Z; Liang X; Jiang B; Shao C; Gong Y
    J Pathol; 2015 Apr; 235(5):784-95. PubMed ID: 25430888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway.
    Chen Z; Tang J; Cai X; Huang Y; Gao Q; Liang L; Tian L; Yang Y; Zheng Y; Hu Y; Tang N
    Cancer Sci; 2016 Oct; 107(10):1380-1389. PubMed ID: 27420729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nucleoporin 93 mediates β-catenin nuclear import to promote hepatocellular carcinoma progression and metastasis.
    Lin CS; Liang Y; Su SG; Zheng YL; Yang X; Jiang N; Fu L; Zhou J; Zhang Y; Deng R; Wang CH; Lu SX; Huang YH; Liu LL; Zhang C; Yun JP
    Cancer Lett; 2022 Feb; 526():236-247. PubMed ID: 34767927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.